Literature DB >> 16714148

Epilepsy, intellectual disability, and living environment: a critical review.

Willeke van Blarikom1, In Y Tan, Albert P Aldenkamp, Ad Th G van Gennep.   

Abstract

Epilepsy occurs at a higher incidence and is more prevalent in people with an intellectual disability than in the general population. Nonetheless, we have insufficient knowledge of the extra needs of people with epilepsy and intellectual disability, of their families, and of the living environment. The lack of information about specific needs of the living environment may, in particular, be important. A Medline search revealed that scant attention has been paid to the specific needs for patients with epilepsy and intellectual disability, and only a few studies have focused specifically on this topic. The majority of studies have been focused on medical treatment issues and the organization and availability of health and social services. There is an indication that people with epilepsy and intellectual disability lack skills training appropriate to their intellectual potential. And although several reviews have emphasized the need for information on living environment and quality of life, we did not find such studies in our search.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16714148     DOI: 10.1016/j.yebeh.2006.04.001

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  12 in total

1.  Effect of carbamazepine or phenytoin therapy on blood level of intravenously administered midazolam: a prospective cohort study.

Authors:  Tomoko Hayashi; Hitoshi Higuchi; Yumiko Tomoyasu; Minako Ishii-Maruhama; Shigeru Maeda; Takuya Miyawaki
Journal:  J Anesth       Date:  2015-08-14       Impact factor: 2.078

2.  In vitro changes in the proportion of protein-unbound-free propofol induced by valproate.

Authors:  Minako Ishii-Maruhama; Hitoshi Higuchi; Mai Nakanou; Yuka Honda-Wakasugi; Akiko Yabuki-Kawase; Shigeru Maeda; Takuya Miyawaki
Journal:  J Anesth       Date:  2018-07-30       Impact factor: 2.078

3.  Epilepsy and other central nervous system diseases in atypical autism: a case control study.

Authors:  Svend Erik Mouridsen; Bente Rich; Torben Isager
Journal:  J Neural Transm (Vienna)       Date:  2011-01-05       Impact factor: 3.575

Review 4.  Epilepsy and autism: neurodevelopmental perspective.

Authors:  Roberto Tuchman; Michael Cuccaro
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

5.  Association of epilepsy and comorbid conditions.

Authors:  Michael Seidenberg; Dalin T Pulsipher; Bruce Hermann
Journal:  Future Neurol       Date:  2009-09-01

6.  Epilepsy among children and adolescents with autism spectrum disorders: a population-based study.

Authors:  Elina Jokiranta; Andre Sourander; Auli Suominen; Laura Timonen-Soivio; Alan S Brown; Matti Sillanpää
Journal:  J Autism Dev Disord       Date:  2014-10

7.  The association between epilepsy and autism symptoms and maladaptive behaviors in children with autism spectrum disorder.

Authors:  Emma W Viscidi; Ashley L Johnson; Sarah J Spence; Stephen L Buka; Eric M Morrow; Elizabeth W Triche
Journal:  Autism       Date:  2013-10-28

8.  Description of environmental determinants of quality of life in children with intellectual disability in Japan using the Delphi technique.

Authors:  Luyinga Kalay; Saeko Fujimori; Hanako Suzuki; Keiko Minamoto; Kimiyo Ueda; Chang-Nian Wei; Akemi Tomoda; Koichi Harada; Atsushi Ueda
Journal:  Environ Health Prev Med       Date:  2009-10-07       Impact factor: 3.674

9.  Wordless intervention for epilepsy in learning disabilities (WIELD): study protocol for a randomized controlled feasibility trial.

Authors:  Marie-Anne Durand; Bob Gates; Georgina Parkes; Asif Zia; Karin Friedli; Garry Barton; Howard Ring; Linda Oostendorp; David Wellsted
Journal:  Trials       Date:  2014-11-20       Impact factor: 2.279

10.  Wordless intervention for people with epilepsy and learning disabilities (WIELD): a randomised controlled feasibility trial.

Authors:  Silvana E Mengoni; Bob Gates; Georgina Parkes; David Wellsted; Garry Barton; Howard Ring; Mary Ellen Khoo; Deela Monji-Patel; Karin Friedli; Asif Zia; Lisa Irvine; Marie-Anne Durand
Journal:  BMJ Open       Date:  2016-11-10       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.